TGR BioSciences executes patent strategy facilitating successful merger with Sygnis
Client(s) TGR BioSciences Pty Ltd
Jones Day developed and executed the patent strategy to support TGR BioSciences Pty Ltd's immunoassay technology in its merger with Sygnis AG.